In silico Strategy: A Promising Implement in the Development of Multitarget Drugs against Neurodegenerative Diseases

Author:

Banjare Purusottam12,Wamanrao Matore Balaji1,Murmu Anjali1,Kumar Vikash1,Singh Jagadish1,Roy Partha Pratim1

Affiliation:

1. Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, 495009, India

2. Department of Pharmaceutical Chemistry, Apollo College of Pharmacy, Durg, 491001, India

Abstract

Abstract: Multi-target drug development (MTDD) is the demand of the recent era, especially in the case of multi-factorial conditions such as cancer, depression, neurodegenerative diseases (NDs), etc. The MTDD approaches have many advantages; avoidance of drug-drug interactions, predictable pharmacokinetic profile, and less drug resistance. The wet lab practice in MTDD is very challenging for the researchers, and the chances of late-stage failure are obvious. Identification of an appropriate target (Target fishing) is another challenging task in the development of multi-target drugs. The in silico tools will be one of the promising tools in the MTDD for the NDs. Therefore the outlook of the review comprises a short description of NDs, target associated with different NDs, in silico studies so far done for MTDD for various NDs. The main thrust of this review is to explore the present and future aspects of in silico tools used in MTDD for different NDs in combating the challenge of drug development and the application of various in silico tools to solve the problem of target fishing.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,General Medicine

Reference211 articles.

1. Ramsay R.R.; Popovic-Nikolic M.R.; Nikolic K.; Uliassi E.; Bolognesi M.L.; A Perspective on Multi-target Drug Discovery and Design for Complex Diseases. Clin Transl Med 2018,7

2. Saginc G.; Voellmy F.; Linding R.; Cancer Systems Biology: Harnessing off-Target Effects. Nat Chem Biol 2017,13,1204-1205

3. Klaeger S.; Heinzlmeir S.; Wilhelm M.; Polzer H.; Vick B.; Koenig P.-A.; Reinecke M.; Ruprecht B.; Petzoldt S.; Meng C.; Zecha J.; Reiter K.; Qiao H.; Helm D.; Koch H.; Schoof M.; Canevari G.; Casale E.; Depaolini S.R.; Feuchtinger A.; Wu Z.; Schmidt T.; Rueckert L.; Becker W.; Huenges J.; Garz A.-K.; Gohlke B.-O.; Zolg D.P.; Kayser G.; Vooder T.; Preissner R.; Hahne H.; Tõnisson N.; Kramer K.; Götze K.; Bassermann F.; Schlegl J.; Ehrlich H.-C.; Aiche S.; Walch A.; Greif P.A.; Schneider S.; Felder E.R.; Ruland J.; Médard G.; Jeremias I.; Spiekermann K.; Kuster B.; 2017

4. Hopkins A.L.; Network Pharmacology: The next Paradigm in Drug Discovery. Nat Chem Biol 2008,4,682-690

5. Pilpel Y.; Sudarsanam P.; Church G.M.; Identifying Regulatory Networks by Combinatorial Analysis of Promoter Elements. Nat Genet 2001,29,153-159

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3